Reviews Opana ER


No reviews yet.

Opana ER Drug Description
OPANA® ER
(oxymorphone hydrochloride) Extended-Release Tablets
5 mg, 10 mg, 20 mg, and 40 mg

WARNING:
OPANA ER contains oxymorphone, which is a morphine-like opioid agonist and
a Schedule II controlled substance, with an abuse liability similar to other
opioid analgesics.
Oxymorphone can be abused in a manner similar to other opioid agonists,
legal or illicit. This should be considered when prescribing or dispensing OPANA
ER in situations where the physician or pharmacist is concerned about an increased
risk of misuse, abuse, or diversion.
OPANA ER is an extended-release oral formulation of oxymorphone indicated
for the management of moderate to severe pain when a continuous, around-the-clock
opioid analgesic is needed for an extended period of time.
OPANA ER is NOT intended for use as a prn analgesic.
OPANA ERTABLETS are to be swallowed whole and are not to be broken, chewed,
dissolved, or crushed. Taking broken, chewed, dissolved, or crushed OPANA ER
TABLETS leads to rapid release and absorption of a potentially fatal dose of
oxymorphone.
Patients must not consume alcoholic beverages, or prescription or non-prescription
medications containing alcohol, while on OPANA ER therapy. The co-ingestion
of alcohol with OPANA ER may result in increased plasma levels and a potentially
fatal overdose of oxymorphone.

DRUG DESCRIPTION



What are the possible side effects of oxymorphone (Opana, Opana ER)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

shallow breathing, slow heartbeat;
seizure (convulsions);
cold, clammy skin;
confusion;
severe weakness or dizziness; or
feeling light-headed, fainting.

Less serious side effects...
Read All Potential Side Effects for Opana ER »




OPANA ER (oxymorphone hydrochloride) extended-release, is a semi-synthetic
opioid analgesic supplied in 5 mg, 10 mg, 20 mg, and 40 mg tablet strengths
for oral administration. The tablet strength describes the amount of oxymorphone
hydrochloride per tablet. The tablets contain the following inactive ingredients:
hypromellose, iron oxide black, methylparaben, propylene glycol, silicified
microcrystalline cellulose, sodium stearyl fumarate, TIMERx® -N, titanium
dioxide, and triacetin. The 5 mg, 10 mg and 20 mg tablets also contain macrogol,
and polysorbate 80. In addition, the 5 mg tablets contain iron oxide red. The
10 mg tablets contain FD&C yellow No. 6. The 20 mg tablets contain FD&C
blue No. 1, FD&C yellow No. 6, and D&C yellow No. 10. The 40 mg tablets
contain FD&C yellow No. 6, D&C yellow No. 10, and lactose monohydrate.
Chemically, oxymorphone hydrochloride is 4, 5α -epoxy-3, 14-dihydroxy-17-methylmorphinan-6-one
hydrochloride, a white or slightly off-white, odorless powder, which is sparingly
soluble in alcohol and ether, but freely soluble in water. The molecular weight
of oxymorphone hydrochloride is 337.80. The pKa1 and pKa2
of oxymorphone at 37°C are 8.17 and 9.54, respectively. The octanol/aqueous
partition coefficient at 37°C and pH 7.4 is 0.98.
The structural formula for oxymorphone hydrochloride is as follows:







The tablet strengths, 5, 10, 20 and 40 mg, describe the amount of oxymorphone hydrochloride per tablet.Last reviewed on RxList: 7/27/2007




Opana ER Drug Description
OPANA® ER
(oxymorphone hydrochloride) Extended-Release Tablets
5 mg, 10 mg, 20 mg, and 40 mg

WARNING:
OPANA ER contains oxymorphone, which is a morphine-like opioid agonist and
a Schedule II controlled substance, with an abuse liability similar to other
opioid analgesics.
Oxymorphone can be abused in a manner similar to other opioid agonists,
legal or illicit. This should be considered when prescribing or dispensing OPANA
ER in situations where the physician or pharmacist is concerned about an increased
risk of misuse, abuse, or diversion.
OPANA ER is an extended-release oral formulation of oxymorphone indicated
for the management of moderate to severe pain when a continuous, around-the-clock
opioid analgesic is needed for an extended period of time.
OPANA ER is NOT intended for use as a prn analgesic.
OPANA ERTABLETS are to be swallowed whole and are not to be broken, chewed,
dissolved, or crushed. Taking broken, chewed, dissolved, or crushed OPANA ER
TABLETS leads to rapid release and absorption of a potentially fatal dose of
oxymorphone.
Patients must not consume alcoholic beverages, or prescription or non-prescription
medications containing alcohol, while on OPANA ER therapy. The co-ingestion
of alcohol with OPANA ER may result in increased plasma levels and a potentially
fatal overdose of oxymorphone.

DRUG DESCRIPTION



What are the possible side effects of oxymorphone (Opana, Opana ER)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

shallow breathing, slow heartbeat;
seizure (convulsions);
cold, clammy skin;
confusion;
severe weakness or dizziness; or
feeling light-headed, fainting.

Less serious side effects...
Read All Potential Side Effects for Opana ER »




OPANA ER (oxymorphone hydrochloride) extended-release, is a semi-synthetic
opioid analgesic supplied in 5 mg, 10 mg, 20 mg, and 40 mg tablet strengths
for oral administration. The tablet strength describes the amount of oxymorphone
hydrochloride per tablet. The tablets contain the following inactive ingredients:
hypromellose, iron oxide black, methylparaben, propylene glycol, silicified
microcrystalline cellulose, sodium stearyl fumarate, TIMERx® -N, titanium
dioxide, and triacetin. The 5 mg, 10 mg and 20 mg tablets also contain macrogol,
and polysorbate 80. In addition, the 5 mg tablets contain iron oxide red. The
10 mg tablets contain FD&C yellow No. 6. The 20 mg tablets contain FD&C
blue No. 1, FD&C yellow No. 6, and D&C yellow No. 10. The 40 mg tablets
contain FD&C yellow No. 6, D&C yellow No. 10, and lactose monohydrate.
Chemically, oxymorphone hydrochloride is 4, 5α -epoxy-3, 14-dihydroxy-17-methylmorphinan-6-one
hydrochloride, a white or slightly off-white, odorless powder, which is sparingly
soluble in alcohol and ether, but freely soluble in water. The molecular weight
of oxymorphone hydrochloride is 337.80. The pKa1 and pKa2
of oxymorphone at 37°C are 8.17 and 9.54, respectively. The octanol/aqueous
partition coefficient at 37°C and pH 7.4 is 0.98.
The structural formula for oxymorphone hydrochloride is as follows:







The tablet strengths, 5, 10, 20 and 40 mg, describe the amount of oxymorphone hydrochloride per tablet.Last reviewed on RxList: 7/27/2007




Opana ER Drug Description
OPANA® ER
(oxymorphone hydrochloride) Extended-Release Tablets
5 mg, 10 mg, 20 mg, and 40 mg

WARNING:
OPANA ER contains oxymorphone, which is a morphine-like opioid agonist and
a Schedule II controlled substance, with an abuse liability similar to other
opioid analgesics.
Oxymorphone can be abused in a manner similar to other opioid agonists,
legal or illicit. This should be considered when prescribing or dispensing OPANA
ER in situations where the physician or pharmacist is concerned about an increased
risk of misuse, abuse, or diversion.
OPANA ER is an extended-release oral formulation of oxymorphone indicated
for the management of moderate to severe pain when a continuous, around-the-clock
opioid analgesic is needed for an extended period of time.
OPANA ER is NOT intended for use as a prn analgesic.
OPANA ERTABLETS are to be swallowed whole and are not to be broken, chewed,
dissolved, or crushed. Taking broken, chewed, dissolved, or crushed OPANA ER
TABLETS leads to rapid release and absorption of a potentially fatal dose of
oxymorphone.
Patients must not consume alcoholic beverages, or prescription or non-prescription
medications containing alcohol, while on OPANA ER therapy. The co-ingestion
of alcohol with OPANA ER may result in increased plasma levels and a potentially
fatal overdose of oxymorphone.

DRUG DESCRIPTION



What are the possible side effects of oxymorphone (Opana, Opana ER)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

shallow breathing, slow heartbeat;
seizure (convulsions);
cold, clammy skin;
confusion;
severe weakness or dizziness; or
feeling light-headed, fainting.

Less serious side effects...
Read All Potential Side Effects for Opana ER »




OPANA ER (oxymorphone hydrochloride) extended-release, is a semi-synthetic
opioid analgesic supplied in 5 mg, 10 mg, 20 mg, and 40 mg tablet strengths
for oral administration. The tablet strength describes the amount of oxymorphone
hydrochloride per tablet. The tablets contain the following inactive ingredients:
hypromellose, iron oxide black, methylparaben, propylene glycol, silicified
microcrystalline cellulose, sodium stearyl fumarate, TIMERx® -N, titanium
dioxide, and triacetin. The 5 mg, 10 mg and 20 mg tablets also contain macrogol,
and polysorbate 80. In addition, the 5 mg tablets contain iron oxide red. The
10 mg tablets contain FD&C yellow No. 6. The 20 mg tablets contain FD&C
blue No. 1, FD&C yellow No. 6, and D&C yellow No. 10. The 40 mg tablets
contain FD&C yellow No. 6, D&C yellow No. 10, and lactose monohydrate.
Chemically, oxymorphone hydrochloride is 4, 5α -epoxy-3, 14-dihydroxy-17-methylmorphinan-6-one
hydrochloride, a white or slightly off-white, odorless powder, which is sparingly
soluble in alcohol and ether, but freely soluble in water. The molecular weight
of oxymorphone hydrochloride is 337.80. The pKa1 and pKa2
of oxymorphone at 37°C are 8.17 and 9.54, respectively. The octanol/aqueous
partition coefficient at 37°C and pH 7.4 is 0.98.
The structural formula for oxymorphone hydrochloride is as follows:







The tablet strengths, 5, 10, 20 and 40 mg, describe the amount of oxymorphone hydrochloride per tablet.Last reviewed on RxList: 7/27/2007




Opana ER Drug Description
OPANA® ER
(oxymorphone hydrochloride) Extended-Release Tablets
5 mg, 10 mg, 20 mg, and 40 mg

WARNING:
OPANA ER contains oxymorphone, which is a morphine-like opioid agonist and
a Schedule II controlled substance, with an abuse liability similar to other
opioid analgesics.
Oxymorphone can be abused in a manner similar to other opioid agonists,
legal or illicit. This should be considered when prescribing or dispensing OPANA
ER in situations where the physician or pharmacist is concerned about an increased
risk of misuse, abuse, or diversion.
OPANA ER is an extended-release oral formulation of oxymorphone indicated
for the management of moderate to severe pain when a continuous, around-the-clock
opioid analgesic is needed for an extended period of time.
OPANA ER is NOT intended for use as a prn analgesic.
OPANA ERTABLETS are to be swallowed whole and are not to be broken, chewed,
dissolved, or crushed. Taking broken, chewed, dissolved, or crushed OPANA ER
TABLETS leads to rapid release and absorption of a potentially fatal dose of
oxymorphone.
Patients must not consume alcoholic beverages, or prescription or non-prescription
medications containing alcohol, while on OPANA ER therapy. The co-ingestion
of alcohol with OPANA ER may result in increased plasma levels and a potentially
fatal overdose of oxymorphone.

DRUG DESCRIPTION



What are the possible side effects of oxymorphone (Opana, Opana ER)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

shallow breathing, slow heartbeat;
seizure (convulsions);
cold, clammy skin;
confusion;
severe weakness or dizziness; or
feeling light-headed, fainting.

Less serious side effects...
Read All Potential Side Effects for Opana ER »




OPANA ER (oxymorphone hydrochloride) extended-release, is a semi-synthetic
opioid analgesic supplied in 5 mg, 10 mg, 20 mg, and 40 mg tablet strengths
for oral administration. The tablet strength describes the amount of oxymorphone
hydrochloride per tablet. The tablets contain the following inactive ingredients:
hypromellose, iron oxide black, methylparaben, propylene glycol, silicified
microcrystalline cellulose, sodium stearyl fumarate, TIMERx® -N, titanium
dioxide, and triacetin. The 5 mg, 10 mg and 20 mg tablets also contain macrogol,
and polysorbate 80. In addition, the 5 mg tablets contain iron oxide red. The
10 mg tablets contain FD&C yellow No. 6. The 20 mg tablets contain FD&C
blue No. 1, FD&C yellow No. 6, and D&C yellow No. 10. The 40 mg tablets
contain FD&C yellow No. 6, D&C yellow No. 10, and lactose monohydrate.
Chemically, oxymorphone hydrochloride is 4, 5α -epoxy-3, 14-dihydroxy-17-methylmorphinan-6-one
hydrochloride, a white or slightly off-white, odorless powder, which is sparingly
soluble in alcohol and ether, but freely soluble in water. The molecular weight
of oxymorphone hydrochloride is 337.80. The pKa1 and pKa2
of oxymorphone at 37°C are 8.17 and 9.54, respectively. The octanol/aqueous
partition coefficient at 37°C and pH 7.4 is 0.98.
The structural formula for oxymorphone hydrochloride is as follows:







The tablet strengths, 5, 10, 20 and 40 mg, describe the amount of oxymorphone hydrochloride per tablet.Last reviewed on RxList: 7/27/2007




Opana ER Drug Description
OPANA® ER
(oxymorphone hydrochloride) Extended-Release Tablets
5 mg, 10 mg, 20 mg, and 40 mg

WARNING:
OPANA ER contains oxymorphone, which is a morphine-like opioid agonist and
a Schedule II controlled substance, with an abuse liability similar to other
opioid analgesics.
Oxymorphone can be abused in a manner similar to other opioid agonists,
legal or illicit. This should be considered when prescribing or dispensing OPANA
ER in situations where the physician or pharmacist is concerned about an increased
risk of misuse, abuse, or diversion.
OPANA ER is an extended-release oral formulation of oxymorphone indicated
for the management of moderate to severe pain when a continuous, around-the-clock
opioid analgesic is needed for an extended period of time.
OPANA ER is NOT intended for use as a prn analgesic.
OPANA ERTABLETS are to be swallowed whole and are not to be broken, chewed,
dissolved, or crushed. Taking broken, chewed, dissolved, or crushed OPANA ER
TABLETS leads to rapid release and absorption of a potentially fatal dose of
oxymorphone.
Patients must not consume alcoholic beverages, or prescription or non-prescription
medications containing alcohol, while on OPANA ER therapy. The co-ingestion
of alcohol with OPANA ER may result in increased plasma levels and a potentially
fatal overdose of oxymorphone.

DRUG DESCRIPTION



What are the possible side effects of oxymorphone (Opana, Opana ER)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have any of these serious side effects:

shallow breathing, slow heartbeat;
seizure (convulsions);
cold, clammy skin;
confusion;
severe weakness or dizziness; or
feeling light-headed, fainting.

Less serious side effects...
Read All Potential Side Effects for Opana ER »




OPANA ER (oxymorphone hydrochloride) extended-release, is a semi-synthetic
opioid analgesic supplied in 5 mg, 10 mg, 20 mg, and 40 mg tablet strengths
for oral administration. The tablet strength describes the amount of oxymorphone
hydrochloride per tablet. The tablets contain the following inactive ingredients:
hypromellose, iron oxide black, methylparaben, propylene glycol, silicified
microcrystalline cellulose, sodium stearyl fumarate, TIMERx® -N, titanium
dioxide, and triacetin. The 5 mg, 10 mg and 20 mg tablets also contain macrogol,
and polysorbate 80. In addition, the 5 mg tablets contain iron oxide red. The
10 mg tablets contain FD&C yellow No. 6. The 20 mg tablets contain FD&C
blue No. 1, FD&C yellow No. 6, and D&C yellow No. 10. The 40 mg tablets
contain FD&C yellow No. 6, D&C yellow No. 10, and lactose monohydrate.
Chemically, oxymorphone hydrochloride is 4, 5α -epoxy-3, 14-dihydroxy-17-methylmorphinan-6-one
hydrochloride, a white or slightly off-white, odorless powder, which is sparingly
soluble in alcohol and ether, but freely soluble in water. The molecular weight
of oxymorphone hydrochloride is 337.80. The pKa1 and pKa2
of oxymorphone at 37°C are 8.17 and 9.54, respectively. The octanol/aqueous
partition coefficient at 37°C and pH 7.4 is 0.98.
The structural formula for oxymorphone hydrochloride is as follows:







The tablet strengths, 5, 10, 20 and 40 mg, describe the amount of oxymorphone hydrochloride per tablet.Last reviewed on RxList: 7/27/2007





Other reviews about Opana ER on wordpress

Buy Opana Er Online Order Cheap Opana Er Generic Purchase Discount Without Prescription
  by worlddnews
FOLLOW THIS LINK FOR ENTER TO TRUSTED & REPUTABLE ONLINE DRUGSTORE WHERE YOU CAN GET ALL QUALIFIED INFORMATION ABOUT Opana Er ONLINE     Medicines that can cause hair a cold […]


News, News, News
  by kerriesmyres
There is never enough time for me to post about all that I want to write about. And there's been a ton of headache news lately. Here are […]


Data Feed
  by misstrade
Bond Watch: Still Bid The market is seeing some buying heading into the final session of the quarter. Bonds were bought globally as equities trailed off overnight on […]


Penwest Pharmaceuticals (PPCO) Set For Huge Fall
  by 247wallst
According to The Associated Press Endo Pharmaceuticals (ENDP). and Penwest Pharmaceuticals (PPCO). said Wednesday the patent on their pain drug Opana ER is being challenged by Impax Laboratories […]


After Hours
  by misstrade
17:32 EAT Brinker announces prelim Q2 EPS below consensus; Reports Preliminary Comparable Restaurant Sales ... 17:30 SGEN Seattle Genetics Earns Milestone Payment from Initiation of SGN-40 Phase Ib […]


Endo Pharmaceuticals: A Growth Story
  by Measured Approach
Endo Pharmaceuticals Holdings Inc. (ENDP), is a specialty pharmaceutical company. Their particular niche is pain management. The company develops and sells branded and generic pharmaceuticals used primarily to […]


Pain Medicine - a new department more Medical residents must be aware of
  by bonjupatten
PAIN MEDICINE has been in the news lately since Michael Jackson's demise from prescription pain medicine, which in his case, was administered by a heart specialist instead of […]


The Last
  by Julie
Awhile back, while I was pregnant with Jonas, a Nurse Practitioner I saw on one of my visits informed me that I absolutely HAD to have physical therapy […]


Getting Rid Of: Medications (Properly!)
  by asopo
Everyone knows you should NEVER flush your medications down the toilet…. right? RIGHT? You should always take unused or expired medications back to the pharmacy […]


Midday Market Movers (NASDAQ: PPCO) (NYSE: CASC)
  by World Market Media
Penwest Pharmaceuticals Co. (NASDAQ: PPCO) is trading at 3.26, up .48 or 17.27%. Today, Penwest and Endo Pharmaceuticals settled litigation with Impax Laboratories regarding the production and sale […]



Other reviews about Opana ER on web:

OPANA ER and OPANA oxymorphone tablets information for healthcare professionals in pain management OPANA® ER (oxymorphone HCl tablets) and OPANA® (oxymorphone HCl ...


Learn about the prescription medication Opana ER (Oxymorphone Hydrochloride Extended Release), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient ... Opana ER (Oxymorphone Hydrochloride Extended Release) Drug ...


Opana 10 mg red, round tablet. Opana ER 5 mg pink, octagon film-coated tablet. Opana ER 10 mg light orange, octagon film-coated tablet. Opana ER 20 mg light green, octagon film-coated ... Opana Information from Drugs.com


OPANA ER and OPANA oxymorphone tablets information for healthcare professionals in pain management Home [www.opana.com]


Accurate, FDA approved Opana ER information for healthcare professionals and patients - brought to you by Drugs.com. Opana ER Official FDA information, side effects and uses.


OPANA ER (Oxymorphone) drug information for Pain, general~narcotics from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions. OPANA ER (Oxymorphone) drug information from MPR


opana er articles and discussion threads. Learn about and discuss opana er at The People's Medicine Community. Opana Er - Topics - The People's Medicine Community


I have been on Opana ER for the passed 9 months. Of all the meds I have been prescribed (ie Avinza, oxycodone, methadone) none can hold a candle next to Opana. Opana ER | Pharmer.org


My dr wants to put me on Opana ER. Has anyone been put on it and what are the results?, Karel... Opana ER Information, Learn About Opana ER, Opana ER Forums, How to Take Opana ... Opana ER - The People's Medicine Community


Opana ER is a brand name; its generic name is oxymorphone. This drug belongs to a group of narcotic agonists that relieve moderate to severe pain in adults. It is a pre operative ... Opana Er - Kosmix : Reference, Videos, Images, News, Shopping and ...





Featured Reviews

Reviews Clomid

Clomid Drug Description CLOMID® (clomiphene citrate) Tablets USP DRUG DESCRIPTION What are the possible side effects of clomiphene (Clomid, Serophene)? Stop taking clomiphene and seek emergency medical attention if you experience...
Read More  |  Review This
Reviews Hydrocortisone Probutate Cream

Pandel Drug Description Pandel® (hydrocortisone probutate cream) Cream, 0.1% For Dermatologic Use Only Not for Ophthalmic Use DRUG DESCRIPTION Pandel Cream contains hydrocortisone probutate, a synthetic adrenocorticosteroid, ...
Read More  |  Review This
Reviews Remodulin

Remodulin Drug Description REMODULIN (treprostinil) Injection DRUG DESCRIPTION What are the possible side effects of treprostinil (Remodulin)? Get emergency medical help if you have any of these signs of an allergic reaction: hives;...
Read More  |  Review This
Reviews Nuromax

Nuromax Drug Description NUROMAX (doxacurium chloride) Injection This drug should be administered only by adequately trained individuals familiar with its actions, characteristics, and hazards. DRUG DESCRIPTION NUROMAX (doxacurium...
Read More  |  Review This
Reviews Leuprolide Acetate Injection

Lupron Depot 3.75 mg Drug Description LUPRON DEPOT (leuprolide acetate) Injection, Powder, Lyophilized, for Suspension DRUG DESCRIPTION What are the possible side effects of leuprolide (Eligard, Lupron, Lupron Depot, Lupron Depot-Gyn,...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....